The Role of Minimally Invasive Surgery in the Management of Inflammatory Bowel Disease: Current Trends and Future Directions
Sanskruti Rathod, Nishant Kumar, German D Matiz, Sheryl Biju, Peter Girgis, Nagma Sabu, Hassan Mumtaz, Ali Haider

TL;DR
Minimally invasive surgery improves outcomes for inflammatory bowel disease, with single-incision and robotic techniques showing promise.
Contribution
This review highlights current MIS trends and predicts future adoption of single-incision and robotic techniques in IBD surgery.
Findings
Conventional multiport laparoscopy is the most common MIS for IBD.
Single-incision laparoscopy shows better results than multiport techniques.
Robotic surgery is effective but limited by cost and longer operation times.
Abstract
Minimally invasive surgery (MIS) provides superior results in the surgical treatment of inflammatory bowel disease (IBD). There exist various minimally invasive procedures, each possessing its own set of benefits and drawbacks. This literature review outlines these methodologies and underscores their importance in enhancing the outcomes of patients with IBD. A grand total of 192 studies were carefully chosen and succinctly summarized. Conventional multiport laparoscopy is the most widely used MIS for IBD, with single-incision laparoscopy showing even better results. Robotic surgery offers comparable results but at higher costs and longer operation times. In the future, there will be widespread acceptance of single-incision laparoscopy and robotic surgery due to improved training and reduced expenses. Further research into the technology’s utility in different IBD presentations could…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGastrointestinal disorders and treatments · Gastrointestinal Tumor Research and Treatment · Gastrointestinal Bleeding Diagnosis and Treatment
Introduction and background
Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive system, primarily characterized by ulcerative colitis (UC) and Crohn’s disease (CD). The exact cause is unknown, but factors include environmental, genetic, and gut microbiota [1]. Colonoscopy with biopsies is the gold standard for diagnosis because it can distinguish between the characteristic findings of UC and those of CD.
UC is a chronic colon inflammation causing mucosal and submucosal ulcers. It’s caused by abnormal bacteria-immune interactions, causing increased permeability and proinflammatory cytokine secretion. Symptoms include bloody diarrhea, abdominal pain, and complications [2-4]. CD is a bimodal disease that causes inflammation, tissue damage, and fibrotic scarring in the digestive tract. It affects any part of the digestive tract and is associated with skip lesions. Patients with terminal ileum pain often present with lymphoid aggregates and granulomas [5-7]. In the 21st century, there has been a progressive incline in the incidence of IBD as a global disease in newly industrialized countries. The prevalence of IBD has surpassed 0.3% in Oceania, North America, and many countries in Europe [8]. A peak in the incidence of IBD is seen during adolescence or early adulthood, as almost one-quarter of all cases are diagnosed before 18 years of age [9-11].
IBD patients often require surgery due to the disease’s relapsing and remitting nature, with up to 30% of UC and 80% of CD requiring surgery. The ileal pouch-anal anastomosis (IPAA) is the favored procedure, with total proctocolectomy (the removal of the large intestine (the colon) and rectum, leaving the small intestine disconnected from the anus) being the preferred operation. Laparoscopic ileal pouch-anal procedure removes the colon and rectum while creating an internal pouch from a portion of a small intestine, which offers improved short-term outcomes and reduced hernia rates [12-16]. Surgery is recommended for refractory CD patients with severe complications. Common procedures include ileocecal resection, stricturoplasty, and endoscopic dilatation, which are treatments for strictures that can occur after ileocecal resection or right hemicolectomy. Recurrence rates vary, but surgical procedures improve morbidity, reduce trauma, and speed up recovery [17,18]. Minimally invasive surgery (MIS) can reduce the risk of intestinal obstruction, improve visualization, and decrease inflammation. Smaller wounds lead to less postoperative pain and morbidity. Robotic surgery offers advantages like motion scaling and 3D vision. While not all patients with IBD can undergo MIS, it may improve the management of IBD. However, contraindications may exist [19-22].
In this review, we will summarize the current trends in MIS in CD and UC.
Review
Materials and methods
Literature Search Strategy
A comprehensive literature search was conducted using two electronic databases, MEDLINE/PubMed and Google Scholar, to identify studies published between January 2010 and December 2023 on the management of IBD using MIS. The following search terms were used: “Inflammatory Bowel Disease,” “Crohn’s Disease,” “Ulcerative Colitis,” “Minimally Invasive Surgery,” “Laparoscopy,” and “Laparoscopic.”
Inclusion and Exclusion Criteria
Studies were included if they met the following criteria:
-Study design: Primary research including observational studies, cohort studies, case-control studies, and randomized controlled trials.
-Focus: Studies specifically focused on the management of IBD using MIS.
-Language: Published in the English language.
-Time frame: Studies published between January 2010 and December 2023.
Studies were excluded if they were:
-Secondary research: Including narrative reviews, systematic reviews, and meta-analyses.
Data Extraction
Two groups of reviewers independently screened articles based on their titles and abstracts to identify relevant studies from PubMed and Google Scholar. The full texts of the relevant articles were then reviewed to ascertain whether they met the inclusion criteria. A summary table was created using data extracted from each included study, which included study design, sample size, demographics, intervention(s), and relevant outcomes.
Study Design
The included studies encompassed a range of primary research designs, such as observational studies, cohort studies, case-control studies, and randomized controlled trials. These study designs provided a comprehensive understanding of the management of IBD using MIS from various methodological perspectives. The selected time frame for these articles, spanning from January 2010 to December 2023, ensured the inclusion of recent and relevant research, capturing the latest advancements and trends in the field.
Data Synthesis and Summary
Data from the included studies were summarized after reviewing study design, patient characteristics, interventions, and outcomes. The results were presented in a descriptive manner according to the intervention type.
Results
In our literature review, we identified studies evaluating minimally invasive techniques for the surgical management of IBD, which were broadly classified into the following categories: conventional multiport laparoscopy, single-incision or single-port laparoscopy, and robotic or robot-assisted surgery. Below, we summarize the findings from these studies.
Role of MIS in IBD
In our literature review, we came across studies evaluating minimally invasive techniques for surgical management of IBD, which could be broadly classified into the following categories: conventional multiport laparoscopy, single-incision or single-port laparoscopy, and robotic or robot-assisted surgery. The results of studies comparing these approaches are discussed in this section. We also highlight the role of endoscopy and colonoscopy in the diagnosis, management, and surveillance of IBD.
Conventional Multiport Laparoscopy
The extensive body of literature on laparoscopic surgery for the management of IBD provides a comprehensive view of its efficacy and evolving trends. In the investigation of laparoscopic procedures for adult colorectal surgeons and adolescents with IBD, the safety of this combination is explored, offering insights into the feasibility and potential benefits for younger patients [23]. Long-term outcomes following laparoscopically assisted versus open ileocolic resection for CD contribute substantial evidence regarding the comparative effectiveness of laparoscopic techniques, providing a foundation for treatment decisions [24]. The feasibility of laparoscopic restorative proctocolectomy (LRP) without diverting stoma suggests the potential for minimizing invasive interventions, impacting the postoperative quality of life [25].
Adhesions after laparoscopic and open IPAA surgery for UC delineate the postoperative complications associated with different surgical approaches, aiding in refining surgical strategies [26]. The significantly increased pregnancy rates after LRP illuminate the broader impact of MIS on patients’ reproductive health [27].
Short-term outcomes of laparoscopy combined with enhanced recovery pathways shed light on the potential benefits of integrating laparoscopic techniques with enhanced recovery protocols, emphasizing holistic patient care [28]. The study comparing laparoscopic-assisted versus conventional ileocolectomy for primary CD delineates the nuances between these approaches, influencing decision-making in primary CD cases [29].
Preoperative infliximab therapy’s impact on morbidity and mortality after laparoscopic resection for IBD addresses a critical aspect of preoperative management, contributing to a nuanced understanding of the intersection between medical and surgical therapies. The extensive collection of articles underscores the dynamic landscape of laparoscopic surgery for IBD, from procedural nuances to technological advancements. Future trends may involve further integration of robotic assistance, personalized approaches based on patient characteristics, and continued refinement of laparoscopic techniques, as included in the study by Miller et al. on robotic-assisted proctectomy for IBD, which presents a case-matched comparison of laparoscopic and robotic techniques, assessing the role of advanced technologies in improving surgical outcomes [30,31]. As the field evolves, ongoing research will likely explore novel strategies to enhance patient outcomes, reduce complications, and broaden the scope of minimally invasive interventions in the realm of IBD surgery.
Single-Incision or Single-Port Laparoscopy
Single-incision laparoscopy theoretically should offer faster recovery and reduced postoperative pain. There are several studies highlighting multiple benefits of single-incision laparoscopy over conventional laparoscopy for patients with CD, such as reduced hospital stay, reduced postoperative pain scores, and decreased need for analgesia post-surgery [32-34]. The rate of postoperative complications was similar in both groups in these studies. For patients with UC undergoing single-stage proctectomy with single-port laparoscopy, a study done by Li et al. reveals lower estimated blood loss, shorter operative time, and reduced length of stay in the hospital compared with multi-port laparoscopy [35]. Similar results were achieved by Burke et al. [36].
Robotic or Robot-Assisted Surgery
Robotic surgery has been the latest addition to the minimally invasive techniques used in the surgical management of IBD. When compared to the open approach, robot-assisted ileocolic resection for CD was associated with a shorter stay in the hospital and a lower rate of complication within 30 days of the surgery but longer operative times, as demonstrated by Raskin et al. [37]. However, for complex operations like IPAA, robot-assisted surgery offers no advantage over the open approach while incurring higher operative times, as highlighted by Opoku et al. [38]. Robotic surgery offers almost similar postoperative outcomes, including rates of complication, reoperation, and readmission, as compared to conventional laparoscopy, although with higher operative time [39-41].
When outcomes like return to bowel function, length of stay, and estimated blood loss are considered, its advantage over conventional laparoscopy remains unclear, with some studies favoring the robotic approach and some other studies favoring laparoscopy [39-43]. There is a need for a larger study, such as a randomized trial or systematic review with meta-analysis, to get conclusive evidence regarding its disadvantages and advantages over conventional laparoscopy. Moreover, when compared to single-incision laparoscopy, robotic surgery was found to have inferior results with increased estimated blood loss and longer length of stay, according to a study done by Rencuzogullari et al. [44].
There have also been concerns regarding the higher cost of robotic surgery without any clinically significant benefit over conventional laparoscopic surgery, as highlighted by Gebhardt et al. [45]. Advancements in technology and widespread adoption with increased surgeon experience may help reduce costs and operation times.
Role of MIS in Pediatric Population
Minimally invasive techniques gain even more importance in the pediatric population considering the psychological impact of the length of the scar as well the overall quality of life after surgery in children. In our literature review, we found several studies that have highlighted that laparoscopic surgery has better outcomes in terms of lower complication rate and shorter length of stay compared to the open approach in children with UC [46,47].
Similar results were obtained by Quiroz et al. in a study done on children with CD [48]. Studies have also been done on single-incision laparoscopic surgery (SILS) and robot-assisted surgery in children with IBD, and all have highlighted these techniques as a safe and feasible option, but studies comparing these techniques in children with conventional laparoscopy have not yet been done [49-51].
Role of Endoscopy
The comprehensive review of literature on endoscopic interventions within MIS for IBD reveals a multifaceted landscape of evolving approaches and promising outcomes. Laparoendoscopic single-site surgery emerges as a feasible alternative for complex colorectal resections, presenting a potential paradigm shift by enabling day case colectomy [52]. The application of surgical stricturoplasty in treating ileal pouch strictures provides insights into tailored interventions, offering an alternative to conventional surgical methods [53]. Innovative avenues in postoperative care are explored in a study by Fedorak et al., where the probiotic VSL#3 exhibits anti-inflammatory effects, potentially reducing endoscopic recurrence after CD surgery [54].
The intricate relationship between prior use of immunomodulatory drugs and clinical outcomes of endoscopic balloon dilation for intestinal strictures in CD patients is elucidated in the article by Honzawa et al. [55]. A notable contribution comes from a large UK series, as discussed in an article by Karahan and Sevinç, demonstrating the safety and efficacy of endoscopic balloon dilatation for CD strictures [56]. Additionally, the long-term outcomes of serial endoscopic balloon dilation for upper gastrointestinal CD -associated strictures are explored in a cohort study [57].
The collective findings underscore the dynamic nature of endoscopic interventions, emphasizing not only their feasibility and safety but also their potential to impact the quality of life for individuals with CD. The discussion delves into the nuanced aspects of each study, addressing the complexities of patient selection, procedural nuances, and the broader implications for the evolving landscape of IBD management. In conclusion, this review not only consolidates current knowledge but also stimulates further research to refine and integrate endoscopic approaches seamlessly into routine clinical practice for improved patient outcomes in the realm of IBD.
Role of Colonoscopy
The exploration of colonoscopic interventions in the management of IBD unveils a spectrum of studies contributing to the optimization of diagnostic and therapeutic procedures. In the randomized, single-center trial of water-aided colonoscopy, the focus is on enhancing mucosal visualization and patient tolerance. The study provides valuable insights into the potential benefits of incorporating water-assisted techniques, potentially improving procedural outcomes for IBD patients undergoing colonoscopy. In a parallel endeavor, the double-blind, randomized, single-center trial on carbon dioxide insufflation during colonoscopy delves into the comparison between carbon dioxide and traditional air insufflation. The findings bear significance for the minimization of patient discomfort and the enhancement of overall procedural experience in the context of IBD. The combined results highlight the ever-changing characteristics of endoscopic treatments, stressing not only their practicality and lack of risk but also their ability to influence the well-being of persons with Crohn’s disease. Research indicates that CO2 insufflation, when compared to air, effectively reduces stomach discomfort, bloating, and flatulence ratings for at least three hours following colonoscopy in individuals with IBD. This method achieves similar benefits during the procedure itself. A lower level of ferritin was found to be linked to a higher chance of developing IBD in a study that followed participants over time. Iron deficiency was more prevalent in healthy males who later had IBD compared to matched controls, but it was not observed in women. Water-aided colonoscopy is more effective than air insufflation in reducing discomfort in sedated individuals with inflammatory bowel illness who require immediate attention. The procedure also yields similar results in terms of outcomes [58-60].
This study presents a non-invasive approach to assess disease activity after surgery, offering a potential avenue for timely intervention in the postoperative phase. Confocal laser endomicroscopy’s (CLE) pilot study explores its application for the differential diagnosis of UC and CD [61]. The study introduces the prospect of a more accurate diagnostic tool, which could potentially refine treatment strategies based on a precise understanding of the underlying disease. A study conducted by Tontini et al. reveals that CLE has the ability to observe certain microscopic characteristics that are commonly employed in traditional histopathology to distinguish between UC and CD [62]. Nevertheless, due to the restricted ability of CLE to reach deep into tissues, it was not possible to observe submucosal details or granulomas. The novel scoring system has the potential to enable in vivo diagnosis of UC or CD [62]. The study underscores the evolving landscape of novel interventions that can be administered via colonoscopy for the management of IBD. The randomized trial comparing high-definition colonoscopy techniques addresses the critical aspect of lesion detection during IBD surveillance colonoscopy [63].
This study is poised to influence future surveillance strategies, emphasizing the importance of optimizing colonoscopy protocols for improved neoplastic lesion detection. As future trends, these studies collectively suggest a trajectory toward refined colonoscopic techniques for IBD management. The incorporation of advanced imaging modalities, innovative insufflation methods, and the ongoing exploration of non-invasive markers indicate a dynamic evolution within the field. These findings lay the groundwork for enhancing diagnostic accuracy, therapeutic efficacy, and overall patient outcomes in the continually advancing realm of minimally invasive approaches to IBD [64-69].
These findings collectively suggest that minimally invasive techniques offer significant benefits in the management of IBD. Further research, including randomized trials and systematic reviews, is needed to solidify the advantages and address the limitations of these approaches.
Discussion
The findings from our literature review provide a comprehensive overview of the benefits and limitations of minimally invasive techniques in the surgical management of IBD. These techniques, including conventional multiport laparoscopy, single-incision or single-port laparoscopy, and robotic or robot-assisted surgery, have been shown to offer various advantages over traditional open surgery, contributing to improved patient outcomes. In this discussion, we interpret these results and explore their implications for clinical practice.
MIS has gained prominence in the management of IBD, particularly for CD and UC, due to its potential benefits over traditional open surgery. These benefits include reduced postoperative pain, shorter hospital stays, faster recovery times, and improved cosmetic outcomes. This discussion explores the current state of MIS in IBD management, highlights significant advancements, and examines future trends.
Current State of MIS in IBD Management
Laparoscopic surgery: Laparoscopic surgery has been extensively adopted in the management of IBD. Multiple studies have demonstrated its efficacy and safety in both elective and emergency settings. For instance, laparoscopic ileocolic resection for CD is associated with lower morbidity compared to open surgery [66]. Similarly, laparoscopic total proctocolectomy with IPAA for UC results in better fertility outcomes compared to open surgery [64,70-72].
Single-incision laparoscopic surgery: SILS is an evolving technique that further reduces the invasiveness of traditional laparoscopy. Studies have shown that SILS can be feasibly and safely performed for IBD surgeries. There are successful outcomes with SILS for ileocolic resection in CD patients, highlighting reduced postoperative pain and quicker recovery times compared to conventional multiport laparoscopy [73]. Additionally, this article also demonstrates the effectiveness of SILS in pediatric patients with CD [50].
Surgical management of IBD: Even though medical management is the first line of treatment for patients with IBD, the majority of patients may need to undergo surgery at some instance in the course of the disease [74-77]. The main indications for surgery in UC are a refractory course of the disease, emergency indications for severe colitis refractory to medical treatment, and risk of malignant transformation. Total proctocolectomy followed by ileal J pouch with IPAA provides a permanent cure for patients with UC, but the diverting stoma thus significantly affects the quality of life of the patients [78]. Recent advances include performing an LRP without diverting stoma, which reduces the complications associated with open surgery and also improves the postoperative quality of life [79].
A study conducted by Polle et al. reveals that open restorative proctocolectomy (ORP) has a detrimental effect on body image and cosmesis when compared to LRP. The two treatments yield comparable results in terms of functional outcome, quality of life, and morbidity. The benefits of a durable, enhanced body image and cosmesis for this relatively youthful demographic may outweigh the extended surgical durations and increased expenses, especially for females [80]. MIS leads to better patient satisfaction in terms of cosmesis as it may lead to an improved body image as compared to an open surgery [81]. Many benefits are highlighted in studies regarding single-incision or single-port laparoscopic surgery compared to conventional multiport laparoscopic surgery. They are reduced length of stay, lower estimated blood loss, shorter operative time, reduced postoperative pain scores, and reduced need for analgesia post-surgery [82-86]. MIS, including SILS and robot-assisted surgery, is gaining importance in the pediatric population due to better outcomes, such as shorter hospital stays and lower complication rates [87-92]. MIS should be preferred in the pediatric population as multiple surgical scars may have a negative impact on the mental health of the children and may lead to low self-esteem.
Robotic surgery: In recent years, robot-assisted surgery has been performed in the surgical management of IBD. It consists of a surgeon who sits at a console that is detached from the patient with robotic micro instruments and 1080-pixel high-definition 3D cameras. It is possible to create 3D models of the organs in the preoperative period, which helps in better preparation before surgery. It helps augment the surgeon’s dexterity to achieve high precision and accuracy during surgery. It enables telesurgery, which eliminates the need for the physical presence of a surgeon. The disadvantages include high costs, advanced communication technology, and longer operative time [93-95]. Surgeons require additional training and have a steep learning curve as depth perception and tactile perception are lost. Robotic surgery shows similar rates of postoperative complications, readmission, and reoperation as compared to conventional laparoscopic techniques. A study by Raskin et al. demonstrated longer operative time, shorter hospital stays, and a lower rate of 30-day postoperative complications [96].
Recent advances in colorectal robotic surgery include complete robotic surgery with intra-abdominal anastomoses [97]. There is a lack of significant benefit of robotic surgery over laparoscopic surgery, but robotic surgery is beneficial compared to open surgery [98]. Robotic-assisted surgery is increasingly being utilized for IBD management, providing enhanced dexterity and precision. Robotic total proctocolectomy and IPAA have shown comparable short-term outcomes to laparoscopic approaches, with potential benefits in complex cases [70]. Articles report successful robotic ileocolic resections with intracorporeal anastomosis for CD, suggesting the technique’s safety and efficacy [94].
Natural orifice specimen extraction eliminates the need for additional incisions for extraction of resected specimens. This procedure can be performed in patients with UC undergoing colonic resection as well as patients with CD undergoing ileocolic resection and colectomies [99,100].
Significant Advancements in MIS for IBD
Enhanced recovery pathways: The implementation of Enhanced Recovery After Surgery (ERAS) pathway protocols has further improved outcomes for IBD patients undergoing MIS. These pathways focus on multimodal perioperative care, reducing surgical stress and enhancing postoperative recovery [101]. An effective ERAS protocol is proven to be beneficial in colorectal surgery with a shorter hospital stay [101] and decreased morbidity and mortality [102,103]. Studies have demonstrated that ERAS protocols combined with laparoscopic surgery significantly reduce hospital stays and improve patient outcomes [75].
Conventional multiport laparoscopy: Conventional multiport laparoscopy is currently the most popular minimally invasive technique for the surgical management of IBD. Its widespread can be attributed to multiple factors, including the fact that it was the earliest minimally invasive surgical technique to be used, and the first laparoscopic resection for IBD was performed in 1992 [104]. The advantages of laparoscopy over open approach have been demonstrated by multiple studies. The current guideline on the surgical management of CD by The American Society of Colon and Rectal Surgeons (ASCRS) recommends the use of a minimally invasive approach [105]. Similarly, for UC, MIS can be considered when the expertise is available as it leads to lower adhesion and increased fertility preservation according to guidelines on the surgical management of UC by ASCRS [106].
Technological innovations: Technological advancements such as CLE and high-definition colonoscopy have enhanced the diagnostic and therapeutic capabilities of MIS. CLE allows real-time histological examination during endoscopy, aiding in the differential diagnosis of UC and CD [61]. High-definition dye spraying and electronic virtual chromoendoscopy improve the detection of neoplastic lesions during IBD surveillance [63].
Prophylactic and therapeutic endoscopic interventions: The comprehensive literature review on endoscopic interventions within MIS for IBD reveals a multifaceted landscape of evolving approaches and promising outcomes.
Endoscopic balloon dilation and stricturoplasty are minimally invasive alternatives for managing strictures in CD. These interventions have shown favorable outcomes, particularly when combined with immunomodulatory therapy [55]. Additionally, the use of probiotics such as VSL#3 has demonstrated anti-inflammatory effects and reduced endoscopic recurrence after CD surgery [54].
In summary, this review not only compiles current understanding but also promotes additional research to enhance and incorporate endoscopic methods into standard clinical practice, ultimately aiming to improve patient outcomes in the treatment of IBD.
Future Trends in MIS for IBD
Integration of artificial intelligence (AI): AI is expected to revolutionize MIS in IBD by enhancing diagnostic accuracy, predicting surgical outcomes, and personalizing treatment plans. Machine learning algorithms can assist in identifying subtle mucosal changes during endoscopy, improving early detection and intervention.
Expansion of robotic surgery: The adoption of robotic-assisted techniques is likely to increase, driven by ongoing technological improvements and growing surgeon experience. Future studies should focus on long-term outcomes and the cost-effectiveness of robotic surgery compared to traditional MIS approaches.
Development of next-generation surgical instruments: The continuous evolution of surgical instruments, including flexible and miniaturized devices, will further enhance the precision and safety of MIS. Innovations such as single-port robotic platforms and natural orifice transluminal endoscopic surgery (NOTES) hold promise for reducing the invasiveness of IBD surgeries.
Enhanced biologic and targeted therapies: The integration of advanced biologic and targeted therapies with MIS could improve surgical outcomes and reduce recurrence rates. Personalized medicine, guided by genetic and molecular profiling, will enable tailored treatment strategies, optimizing both medical and surgical management of IBD.
In conclusion, MIS has significantly advanced the management of IBD, offering numerous benefits over traditional surgery. Ongoing research and technological innovations will continue to enhance the efficacy and safety of MIS, improving the quality of life for IBD patients.
Future directions
Although there are multiple options available for surgical management of IBD using MIS, only conventional multiport laparoscopy has been able to gain widespread acceptance, as there is a consistent demonstration of its advantages without a disproportionate increase in costs associated with the surgery. However, this does not invalidate the utility of other techniques as evidence of their advantages could emerge with increased use of such techniques in the coming years. Robotic surgery, in particular, is being investigated further in order to determine the scope of its utility in various surgeries for IBD. There has been an increasing focus on reducing the cost of robotic surgeries in order to make them more affordable for patients so that more evidence can be generated about their advantages after they gain widespread usage.
The steep learning curve associated with robotic surgeries is being addressed so that young surgeons can adopt this technique from early on in their careers. Moreover, future investigations into the use of robotic surgery will focus on outcomes that are clinically relevant to the patients. The role of endoscopy in treating IBD is being further explored in order to discover new avenues for its usage. The usage of endoscopy as an adjunct to laparoscopy is also being explored. Single-incision surgery, natural orifice specimen extraction, and transanal MIS (TAMIS) are being further explored as options for the treatment of varying presentations of IBD. The increased usage of these techniques, with evidence being generated in its favor, could result in these techniques being incorporated into standard practice guidelines in the future.
A significant impact of the adoption of these techniques will be on the pediatric population, as reduced psychological impact of the surgery will lead to overall improved quality of life and better self-esteem. As the course of IBD in children can be challenging, any effort made to incorporate MIS as part of treatment protocol in the surgical management of IBD in children should be encouraged. MIS will not just be used for treatment but also for diagnosis, surveillance, and treatment of complications of IBD. This would ensure higher rates of compliance and earlier detection of complications, such as dysplasia, strictures, and recurrence. Timely intervention would increase the overall quality of life of patients suffering from this chronic and complex disease.
Conclusions
IBD is a chronic inflammatory disorder affecting the gastrointestinal tract. Minimally invasive techniques like conventional multiport laparoscopy, single-incision laparoscopy, robot-assisted surgery, endoscopy, and colonoscopy are more effective than traditional open surgical approaches in terms of reduced postoperative pain, shorter hospital stays, faster recovery times, and improved cosmetic outcomes. MIS techniques have shown comparable or superior surgical outcomes, including lower rates of postoperative complications and better long-term disease control. However, challenges such as optimizing surgical strategies and integrating laparoscopic techniques with enhanced recovery pathways remain. In pediatric patients, MIS techniques play a crucial role, offering better outcomes and improved quality of life. Endoscopic interventions, such as laparoendoscopic single-site surgery and endoscopic balloon dilation, show promise in treating IBD-related strictures and reducing postoperative complications. Colonoscopic interventions, like water-aided colonoscopy and fecal calprotectin measurement, offer non-invasive methods for monitoring disease activity and detecting recurrence. However, challenges such as cost, limited accessibility to specialized centers, and the learning curve associated with newer technologies remain important considerations.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1ACG clinical guideline: ulcerative colitis in adults Am J Gastroenterol Rubin DT Ananthakrishnan AN Siegel CA Sauer BG Long MD 38441311420193084060510.14309/ajg.0000000000000152 · doi ↗ · pubmed ↗
- 2Interleukin-13 is the key effector Th 2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology Heller F Florian P Bojarski C 55056412920051608371210.1016/j.gastro.2005.05.002 · doi ↗ · pubmed ↗
- 3A comprehensive review and update on ulcerative colitis Dis Mon Gajendran M Loganathan P Jimenez G 1008516520193083708010.1016/j.disamonth.2019.02.004 · doi ↗ · pubmed ↗
- 4A population-based case control study of potential risk factors for IBD Am J Gastroenterol Bernstein CN Rawsthorne P Cheang M Blanchard JF 993100210120061669678310.1111/j.1572-0241.2006.00381.x · doi ↗ · pubmed ↗
- 5Pathophysiology of Crohn's disease inflammation and recurrence Biol Direct Petagna L Antonelli A Ganini C 231520203316040010.1186/s 13062-020-00280-5PMC 7648997 · doi ↗ · pubmed ↗
- 6Management of active Crohn disease JAMA Cheifetz AS 2150215830920132369548410.1001/jama.2013.4466 PMC 5877483 · doi ↗ · pubmed ↗
- 7Profiling adipocytokine secretion from creeping fat in Crohn's disease Inflamm Bowel Dis Paul G Schäffler A Neumeier M 4714771220061677549010.1097/00054725-200606000-00005 · doi ↗ · pubmed ↗
- 8Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet Ng SC Shi HY Hamidi N 276927783902017 https://www.sciencedirect.com/science/article/abs/pii/S 01406736173244802905064610.1016/S 0140-6736(17)32448-0 · doi ↗ · pubmed ↗
